Nabil F. Saba, Nofisat Ismaila, Francis Worden, Beth M. Beadle. "Reply to: Therapeutic Strategy Concerns for BRAF V600E–Mutated Differentiated Thyroid Cancer." Journal of Clinical Oncology, 2026. doi:10.1200/jco-26-01611